Objectives: To state the correlation between CCL-2, CCL-4 and CXCL-5 serum degrees and remission following traumatic spinal cord injury (TSCI) in a human protocol in comparison with animal research works. Methods: We performed the examination of the serum levels of CCL-2, CCL-4 and CXCL-5 across an eight week duration; especially, at the time of admittance and 4, 9 and 12 h, 1 and 3 days and 1, 2, 4, as well as 8 weeks subsequent to trauma. In accordance with the design of our research, we performed a matching 12 Chinese patients with TSCI as well as neurological remission with 12 Chinese patients having a preliminary ASIA A grade together with no neurological remission. Overall 12 patients having vertebral fracture without neurological shortages acted as control. Our analysis was carried out with the use of a Luminex Cytokine Panel. Results: The observation received through our research exhibited dissimilarities in the serum expression layouts of CCL-2 in relation to the neurological remission (CCL-2 at admission P=0.001). Serum degrees of CCL-2 as well as CCL-4 were considerably varied in patients having or not having neurological remission. Conclusion: As indicated by our findings, peripheral serum analysis is considered as an appropriate idea for the prediction of the patient's capacity for neurological remission subsequent to TSCI. That is why the current research work provides the introduction of a potential technique for prospective inspection of the ideas together with tracking methodologies for the prevalent therapies. As indicated by the findings, prospective examinations with an extended specimen size are required for the purpose of developing inspection, prognostic as well as scoring systems.